Therapeutic signature mapping of paired direct and indirect LPS injury in an ex vivo human lung perfusion platform reveals injury-specific druggable programs
Ahad Abdalla, David A. Dorward, Antonella Pellicoro, Tom Michael Quinn, Stuart Dickson, Adam D. L. Marshall, Annya M. Bruce, John J Cole, Keith Finlayson, Richard A. O’Connor, Chris Haslett, Manu Shankar‐Hari, Kevin Dhaliwal
Direct and indirect LPS injury in human donor lungs produce distinct 4 h proteomic programs; signature reversal favours SYK, CDK, HDAC, JAK/STAT and PI3K/AKT/mTOR pathway modulation.
bioRxiv · Aug 18, 2026 · PreprintImmunology✦ In-depth digest